Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1063 1 |
Ultima descărcare din IBN: 2020-03-26 12:33 |
SM ISO690:2012 DURNEA, Aliona. The Impact of Long Term Medication Ramipril Versus Eprosartane on Renal Function and on Microalbuminuria in Patients with Essential Arterial Hypertension
. In: Curierul Medical, 2011, nr. 3(321), pp. 12-17. ISSN 1875-0666. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Curierul Medical | ||||||
Numărul 3(321) / 2011 / ISSN 1875-0666 | ||||||
|
||||||
Pag. 12-17 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
This research presents the experience of the Arterial Hypertension Department in the treatment of patients with essential hypertension and
microalbuminuria. The study focused on the analysis of clinical observation materials according to the protocol, established in a group of 100 patients, of
whom 50 were treated with angiotensin II converting enzyme inhibitors Ramipril and 50 were treated with angiotensin II receptor antagonist Eprosartane.
Both drugs have proven beneficial effect on renal function parameters, especially in microalbuminuria at all stages of control with a peak at the end of
the follow-up period. However, the treatment with AT1-receptor antagonist Eprosartan has proven to be superior to angiotensin II in converting enzyme
inhibitor Ramipril.
|
||||||
Cuvinte-cheie arterial hypertension, microalbuminuria, angiotensin II converting enzyme inhibitors, angiotensin II receptor antagonist |
||||||
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Durnea, A.S.</dc:creator> <dc:date>2011-05-02</dc:date> <dc:description xml:lang='en'>This research presents the experience of the Arterial Hypertension Department in the treatment of patients with essential hypertension and microalbuminuria. The study focused on the analysis of clinical observation materials according to the protocol, established in a group of 100 patients, of whom 50 were treated with angiotensin II converting enzyme inhibitors Ramipril and 50 were treated with angiotensin II receptor antagonist Eprosartane. Both drugs have proven beneficial effect on renal function parameters, especially in microalbuminuria at all stages of control with a peak at the end of the follow-up period. However, the treatment with AT1-receptor antagonist Eprosartan has proven to be superior to angiotensin II in converting enzyme inhibitor Ramipril. </dc:description> <dc:description xml:lang='ru'>Влияние рамиприла и эпросартана на функциональное состояние почек у пациентов с гипертонической болезнью и микроальбуминурией при длительном лечении В статье излагается собственный опыт лечения 100 пациентов с эссенциальной гипертонией и микроальбуминурией на протяжении 12 месяцев. В I-й группе (50 пациентов) принимали ингибитор ангиотензин-превращающего фермента Рамиприл. Во II-й группе (50 пациентов) принимали блокатор рецепторов ангиотензина II Эпросартан. Результаты исследования свидетельствуют о нефропротективной эффективности не только хорошо знакомого ингибитора ангиотензин-превращающего фермента Рамиприла, но и нового блокатора рецепторов ангиотензина II Эпросартан. </dc:description> <dc:source>Curierul Medical 321 (3) 12-17</dc:source> <dc:subject>arterial hypertension</dc:subject> <dc:subject>microalbuminuria</dc:subject> <dc:subject>angiotensin II converting enzyme inhibitors</dc:subject> <dc:subject>angiotensin II receptor antagonist</dc:subject> <dc:title>The Impact of Long Term Medication Ramipril Versus Eprosartane on Renal Function and on Microalbuminuria in Patients with Essential Arterial Hypertension </dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>